Skip to content

A multicenter randomized controlled study of clinical use of tunneled versus non-tunneled PICC

A multicenter randomized controlled study of clinical use of tunneled versus non-tunneled PICC

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044632
Enrollment
Unknown
Registered
2021-03-24
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

experimental group:tunneled PICC insertion
control group:non-tunneled PICC insertion

Sponsors

Sun Yat-Sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. Patients who underwent PICC catheterization for the first time; 3. No serious cardiovascular diseases, such as atrial fibrillation, cor pulmonale, or severe conduction block, before catheterization; 4. Has not participated in other clinical studies at the same time, and can cooperate with clinical follow-up workers; 5. Volunteered to participate in the study and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Skin damage, infection or scar at the puncture site; 2. Preset tube venous sclerosis, accompanied by cord-like changes and tumor compression of blood vessels; 3. Patients with confirmed or suspected catheter-related infections, bacteremia, or sepsis; 4. Patients with confirmed or suspected silicone allergy; 5. Patients with radiotherapy history at the site of the preset tube; 6. Patients with venous thrombosis, superior vena cava syndrome or a history of vascular surgery; 7. Patients and their family members have poor compliance and are expected to fail to cooperate in completing the clinical study; 8. Periphlebitis patient on the operating side; 9. Patients with high fluid flow, hemodialysis, pacemaker installation, crutches, or possible A-V fistula.

Design outcomes

Primary

MeasureTime frame
incidence of complications;

Secondary

MeasureTime frame
Catheter indwelling time;Unplanned extubation;

Countries

China

Contacts

Public ContactQin Huiying

Sun Yat-Sen University Cancer Center

lijia1@sysucc.org.cn+86 13609756622

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026